Latest news about Zota Healthcare
Zota Healthcare
1,438.50
+7.90(+0.55%)
Company Performance:
View Company Insights1D+0.55%
1M+27.84%
6M-5.37%
1Y+31.92%
5Y+558.50%
More news about Zota Healthcare
06Jun 26
Zota Health Care promoters report no share encumbrance in FY26
Zota Health Care Limited confirmed via a filing to NSE on April 04, 2026, that its promoters and PACs did not pledge any shares during FY26. The declaration, signed by Promoter and Whole-time Director Himanshu Muktilal Zota, covers 39 individuals and entities listed as promoters or promoter group members.
06Jun 26
Zota Health Care to attend Nirmal Bang investor meet on June 15
Zota Health Care Limited will attend a virtual investor conference organized by Nirmal Bang Securities on June 15, 2026. The meeting will include one-on-one and group interactions. The company stated that no unpublished price sensitive information will be shared during the session.
30May 26
Zota Health Care reports FY26 revenue of INR 53,865 lakhs
Zota Health Care Limited released the transcript for its Q4FY26 earnings call, reporting a consolidated revenue of INR 53,865 lakhs for FY26, an 83.86% increase. The Davaindia segment contributed INR 41,741 lakhs, nearly doubling year-on-year. The company achieved positive EBITDA of INR 2,597 lakhs with a margin of 4.82% and expanded its gross margin to 60.28%. Operational highlights include the addition of 997 new stores, bringing the total count to 2,579, and strong same-store growth across mature cohorts. Strategic moves included a INR 350 crores QIP and increasing stake in Everyday Herbal Beauty Care Limited to 87.78%.
27May 26
Zota Health Care to attend investor meet on June 02
Zota Health Care Limited will attend an analyst and institutional investor meeting on June 02, 2026, at Hotel Grand Hyatt, Mumbai. The meeting is part of Axis Capital’s Rising Stars Conference and will feature one-on-one and group discussions. The company confirmed that only public domain information will be shared.
25May 26
Zota Health Care FY26 revenue surges 84% to ₹53,866 lakhs
Zota Health Care Limited reported an 83.86% increase in consolidated revenue to ₹53,865.75 lakhs for FY26, driven by the expansion of its Davaindia retail network to 2,579 stores. While EBITDA turned positive at ₹2,597.73 lakhs, the net loss widened to ₹7,407.74 lakhs. The Board recommended a final dividend of Re. 1 per share and approved strategic acquisitions to strengthen backward integration.
23May 26
Zota caps promoter director remuneration at ₹12 cr till FY2030
Zota Health Care Limited has fixed an upper cap of ₹12 crore for the aggregate annual remuneration of its Promoter Directors, valid till FY2030. The move aims to improve corporate governance and capital allocation. The limit includes all perquisites and allowances and is subject to necessary approvals.
20May 26
Zota Health Care appoints Akshay Kumar as brand ambassador
Zota Health Care Limited has appointed actor Akshay Kumar as brand ambassador for the company and UGO Generic, a B2B and B2C brand under its subsidiary KMHP Ventures. The initiative aims to distribute generic medicines through owned stores and 12.5 lakh retail pharmacies, enhancing national presence.
01Oct 25
Zota Health Care Expands Davaindia Store Network by 310 Outlets in Q2FY26
Zota Healthcare added 310 new Davaindia stores in Q2 FY2026, bringing the total to 2,055. The network now includes 1,207 company-owned company-operated (CoCo) stores and 848 franchise-owned franchise-operated (FoFo) stores. This expansion signifies Zota Healthcare's commitment to growth and could lead to increased market penetration, enhanced brand visibility, improved customer accessibility, and potential revenue growth.
04Sept 25
Zota Health Care Unveils Ambitious 5 Billion Rupee Fundraising Plan
Zota Healthcare's board has approved a plan to raise up to ₹5 billion ($60.50 million) in funds. This significant fundraising initiative aims to strengthen the company's financial position and potentially support expansion plans, production capabilities, R&D investments, and market exploration. The specific details of the fundraising mechanism have not been disclosed.
17Jul 25
Zota Health Care's Surat Facility Receives EU GMP Audit Report
Zota Healthcare has received the European Union Good Manufacturing Practice (EU GMP) audit report for its manufacturing facility in Surat, Gujarat. This audit is a crucial step towards potential expansion into the European pharmaceutical market. The report's receipt indicates that the facility has undergone a thorough inspection of its manufacturing practices. While specific details of the report are not disclosed, this development could lead to market expansion, improved quality assurance, and a competitive edge for Zota Healthcare.
04Jul 25
Zota Healthcare Expands Davaindia Network to 1,760 Stores, Crosses 1,000 CoCo Store Milestone
Zota Healthcare has expanded its Davaindia network to 1,760 operational stores, including over 1,000 Company-Owned Company-Operated (CoCo) stores. This expansion strengthens Zota's market presence in the pharmaceutical retail sector, enhancing its geographical reach and brand visibility.
16May 25
Zota Health Care Expands Davaindia Network to 1,637 Stores
Zota Health Care has expanded its Davaindia network to 1,637 operational stores across India. The company has also reached a milestone of over 901 Company Owned Company Operated (COCO) stores. This expansion significantly increases Zota's retail footprint, potentially enhancing market presence, brand visibility, and direct customer engagement.
18Mar 25
Zota Health Care Expands Reach: Secures Product Registration in Cambodia
Zota Health Care has obtained a product registration license in Cambodia for Azitoz 500, valid for five years. This milestone enables the company to enter the Cambodian pharmaceutical market, potentially increasing sales and market share in Southeast Asia. The extended license period allows Zota Health Care to invest in marketing, distribution, and possible local partnerships, setting a precedent for future international expansion efforts.
17Mar 25
Zota Health Care Expands Reach: Secures Product Registration in Cambodia
Zota Health Care has obtained a five-year product registration license in Cambodia for its medication Azitoz 500. This approval marks a significant step in the company's international expansion strategy, opening up opportunities in the Cambodian pharmaceutical market. The registration validates the product's quality and efficacy, potentially contributing to Zota Health Care's revenue growth and market presence in Southeast Asia.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Dr Reddys Laboratories
Zydus Life Science
Lupin
Mankind Pharma
Aurobindo Pharma
Laurus Labs
1,871.00
(+0.26%)
6,682.50
(+2.09%)
4,661.40
(+0.44%)
1,456.00
(-0.05%)
1,345.70
(+0.43%)
1,099.80
(-0.85%)
2,399.60
(+0.09%)
2,486.90
(-0.14%)
1,561.00
(+0.54%)
1,528.00
(+2.32%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
